Blindness News and Research

RSS

Mutated TREX1 gene linked to catastrophic DNA damage and deadly rare disease

TREX1 is a gene that is supposed to direct the maintenance of the entire body's DNA, but new research shows that when people are born with mutated TREX1, it causes catastrophic damage to the DNA over time, resulting in a deadly rare disease called retinal vasculopathy with cerebral leukoencephalopathy (RVCL).

13 Jun 2024

Doxycycline shows promise in reducing deaths and seizures from nodding syndrome

A new study suggests that a course of the drug doxycycline can decrease acute seizure-related hospitalization and deaths related to nodding syndrome.

8 Jun 2024

Study sheds light on the rate and nature of mutations in mitochondrial DNA

A new study from deCODE genetics uses pedigrees and sequence data from 64,806 Icelanders to shed light on the rate and nature of mutations in mitochondrial DNA (mtDNA) and the peculiar dynamics of its maternal transmission.

7 Jun 2024

New antioxidant biomaterial may provide relief to people living with chronic pancreatitis

Northwestern University researchers have developed a new antioxidant biomaterial that someday could provide much-needed relief to people living with chronic pancreatitis.

7 Jun 2024

New report highlights the urgent need for increased investment in MS research

A new report has revealed the prolonged time to diagnose multiple sclerosis (MS) and highlighted the urgent need for increased investment in MS research and enhanced awareness of the disease.

3 Jun 2024

RNA virus hiding in common human parasite may exacerbate toxoplasmosis

An international team led by researchers at the University of Toronto has found a new RNA virus that they believe is hitching a ride with a common human parasite.

31 May 2024

Delayed multiple sclerosis diagnosis underscores need for urgent research and awareness boost, report find

A new report from MS Australia reveals that the average time to diagnose multiple sclerosis is nearly four years, highlighting the urgent need for increased research investment and enhanced awareness.

29 May 2024

Evaluating the efficacy of harmol in treating herpes simplex virus-induced keratitis

The antiviral efficacy and therapeutic potential of harmol in treating herpes simplex virus type 1 (HSV-1) induced keratitis

29 May 2024

High price of popular diabetes drugs deprives low-income people of effective treatment

For the past year and a half, Tandra Cooper Harris and her husband, Marcus, who both have diabetes, have struggled to fill their prescriptions for the medications they need to control their blood sugar.

21 May 2024

Johns Hopkins researchers identify key electrical activity behind congenital night blindness

In what they believe is a solution to a 30-year biological mystery, neuroscientists at Johns Hopkins Medicine say they have used genetically engineered mice to address how one mutation in the gene for the light-sensing protein rhodopsin results in congenital stationary night blindness.

17 May 2024

Breakthrough imaging technique uncovers detailed scleral patterns in myopic eyes

Eye diseases are extremely prevalent worldwide, with recent estimates suggesting that one-third of the global population suffers from some type of vision impairment.

17 May 2024

Measles vaccine more likely to be completely ineffective in children born by C-section

A study by the University of Cambridge, UK, and Fudan University, China, has found that a single dose of the measles jab is up to 2.6 times more likely to be completely ineffective in children born by C-section, compared to those born naturally.

13 May 2024

New collaboration to combat river blindness and lymphatic filariasis

Prof. Achim Hoerauf, Director of the Institute of Medical Microbiology, Immunology and Parasitology at the University Hospital Bonn (UKB), and his team have succeeded in collaborating with the Department of Pharmaceutical Technology and Biopharmacy at the University of Bonn and the Helmholtz Center for Infection Research (HZI), to enter into a partnership with the Japanese pharmaceutical company Eisai for the further development of the antibiotic corallopyronin A (CorA) as a treatment for the neglected tropical diseases river blindness and lymphatic filariasis and to raise a large amount of funding.

10 May 2024

Clinical trial shows CRISPR gene editing has exciting potential to treat a rare form of blindness

A recent study published in The New England Journal of Medicine investigated the potential use of gene editing to correct a congenital retinal degeneration called CEP290 that causes early-onset vision loss.

8 May 2024

Washington University expands STI testing and treatment services in St. Louis County

In a bid to improve sexual health and reduce health disparities in the St. Louis area, Washington University infectious diseases physicians are expanding testing and treatment services for sexually transmitted infections in north St. Louis County.

7 May 2024

Neuron-sized implant offers hope for vision restoration

A group of researchers from Chalmers University of Technology in Sweden, University of Freiburg and the Netherlands Institute for Neuroscience have created an exceptionally small implant, with electrodes the size of a single neuron that can also remain intact in the body over time – a unique combination that holds promise for future vision implants for the blind.

7 May 2024

CRISPR-based gene editing shows promise in treating rare form of blindness

About 79% of clinical trial participants experienced measurable improvement after receiving experimental, CRISPR-based gene editing that is designed to fix a rare form of blindness, according to a paper published in the New England Journal of Medicine.

6 May 2024

CRISPR gene editing shows promise for treating individuals with a form of inherited blindness

Results from a groundbreaking clinical trial of CRISPR gene editing in 14 individuals with a form of inherited blindness show that the treatment is safe and led to measurable improvements in 11 of the participants treated.

6 May 2024

Revolutionizing treatment for neurological conditions with 3D printed surgical implants

Clever bio-inks that sit inside the human body and restore damaged neurons could cure a whole swathe of diseases in the next 20 years: conditions that have baffled scientists and clinicians for centuries.

6 May 2024

Researchers unveil mechanism enhancing cellular fitness against aging and neurodegeneration

Researchers at Duke University Medical Center discover a mechanism to enhance the fitness of cells against aging and neurodegenerative diseases. This finding will pave the way for novel therapeutic approaches in neuroprotection against aging-related disorders and neurodegeneration.

6 May 2024

Blindness News and Research

Mutated TREX1 gene linked to catastrophic DNA damage and deadly rare disease

Doxycycline shows promise in reducing deaths and seizures from nodding syndrome

Study sheds light on the rate and nature of mutations in mitochondrial DNA

New antioxidant biomaterial may provide relief to people living with chronic pancreatitis

New report highlights the urgent need for increased investment in MS research

RNA virus hiding in common human parasite may exacerbate toxoplasmosis

Delayed multiple sclerosis diagnosis underscores need for urgent research and awareness boost, report find

Evaluating the efficacy of harmol in treating herpes simplex virus-induced keratitis

High price of popular diabetes drugs deprives low-income people of effective treatment

Johns Hopkins researchers identify key electrical activity behind congenital night blindness

Breakthrough imaging technique uncovers detailed scleral patterns in myopic eyes

Measles vaccine more likely to be completely ineffective in children born by C-section

New collaboration to combat river blindness and lymphatic filariasis

Clinical trial shows CRISPR gene editing has exciting potential to treat a rare form of blindness

Washington University expands STI testing and treatment services in St. Louis County

Neuron-sized implant offers hope for vision restoration

CRISPR-based gene editing shows promise in treating rare form of blindness

CRISPR gene editing shows promise for treating individuals with a form of inherited blindness

Revolutionizing treatment for neurological conditions with 3D printed surgical implants

Researchers unveil mechanism enhancing cellular fitness against aging and neurodegeneration

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News